197 related articles for article (PubMed ID: 35872653)
1. Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy.
Gupta R; Jit BP; Kumar S; Mittan S; Tanwer P; Ray MD; Mathur S; Perumal V; Kumar L; Rath GK; Sharma A
Epigenomics; 2022 Jul; 14(14):865-886. PubMed ID: 35872653
[TBL] [Abstract][Full Text] [Related]
2. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
[TBL] [Abstract][Full Text] [Related]
4. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.
Odunsi K; Matsuzaki J; James SR; Mhawech-Fauceglia P; Tsuji T; Miller A; Zhang W; Akers SN; Griffiths EA; Miliotto A; Beck A; Batt CA; Ritter G; Lele S; Gnjatic S; Karpf AR
Cancer Immunol Res; 2014 Jan; 2(1):37-49. PubMed ID: 24535937
[TBL] [Abstract][Full Text] [Related]
6. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets.
Xie K; Fu C; Wang S; Xu H; Liu S; Shao Y; Gong Z; Wu X; Xu B; Han J; Xu J; Xu P; Jia X; Wu J
J Ovarian Res; 2019 Jan; 12(1):1. PubMed ID: 30609934
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic potential value of Cancer-testis antigens in immunotherapy of gastric cancer.
Alsadat Mahmoudian R; Amirhosein M; Mahmoudian P; Fardi Golyan F; Mokhlessi L; Maftooh M; Khazaei M; Nassiri M; Mahdi Hassanian S; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Avan A
Gene; 2023 Feb; 853():147082. PubMed ID: 36464170
[TBL] [Abstract][Full Text] [Related]
10. NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis.
Smith SM; Iwenofu OH
Chin Clin Oncol; 2018 Aug; 7(4):44. PubMed ID: 30173534
[TBL] [Abstract][Full Text] [Related]
11. Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.
Zhang Y; Zhang Y; Zhang L
J Cancer Res Clin Oncol; 2019 Feb; 145(2):281-291. PubMed ID: 30656409
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.
Rao M; Chinnasamy N; Hong JA; Zhang Y; Zhang M; Xi S; Liu F; Marquez VE; Morgan RA; Schrump DS
Cancer Res; 2011 Jun; 71(12):4192-204. PubMed ID: 21546573
[TBL] [Abstract][Full Text] [Related]
13. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
14. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.
Maio M; Coral S; Sigalotti L; Elisei R; Romei C; Rossi G; Cortini E; Colizzi F; Fenzi G; Altomonte M; Pinchera A; Vitale M
J Clin Endocrinol Metab; 2003 Feb; 88(2):748-54. PubMed ID: 12574209
[TBL] [Abstract][Full Text] [Related]
16. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.
Raza A; Merhi M; Inchakalody VP; Krishnankutty R; Relecom A; Uddin S; Dermime S
J Transl Med; 2020 Mar; 18(1):140. PubMed ID: 32220256
[TBL] [Abstract][Full Text] [Related]
17. Gene of the month: cancer testis antigen gene 1b (NY-ESO-1).
Julve M; Kennedy O; Frampton AE; Bagwan I; Lythgoe MP
J Clin Pathol; 2023 Dec; 77(1):1-7. PubMed ID: 37857483
[TBL] [Abstract][Full Text] [Related]
18. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
[TBL] [Abstract][Full Text] [Related]
19. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms.
Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB
Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148
[TBL] [Abstract][Full Text] [Related]
20. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]